Business Context and Reporting Period
This Form 6-K filing by EUDA Health Holdings Ltd (EUDA) covers the month of June 2025. The report details a corporate action taken on June 23, 2025, regarding a new equity financing arrangement.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, or existing debt levels. The primary financial metric disclosed is the potential capital raise:
- Maximum Offering Size: Up to $10,000,000 in ordinary shares.
- Commission Structure: 3.0% of gross proceeds for direct market sales; 7.0% for institutional or block transactions.
Material Changes
The material change reported is the execution of an At The Market (ATM) Offering Agreement with Chardan Capital Markets LLC. This agreement grants the company the option, but not the obligation, to sell shares up to the $10 million limit over time. This represents a new liquidity mechanism compared to the prior period.
Guidance, Outlook, and Risks
Management Commentary: The company retains full discretion over the timing, price, and size of any share sales under the agreement. No sales are guaranteed.
Risks and Contingencies:
- Dilution: Issuance of new shares will dilute existing shareholders.
- Market Conditions: Sales are subject to market conditions and customary parameters set by the company.
- Termination: The offering terminates upon the sale of all shares or earlier termination of the agreement.
Investor Verification Checklist
- Verify the current share price to assess potential dilution impact from the $10 million offering.
- Review the full text of the ATM Agreement (Exhibit 1.1) for specific covenants and termination rights.
- Check the company's existing cash position to determine the urgency of this capital raise.
- Monitor future prospectus supplements for actual sales volumes and pricing.